Molecular imaging of vulnerable plaques in rabbits using contrast-enhanced ultrasound targeting to vascular endothelial growth factor receptor-2

Journal of Clinical Ultrasound

Volumn 39, Issue 2, 2011, Pages 83-90

  Liu, Hong ^a   Wang, Xiang ^a   Tan, Kai Bing ^a   Liu, Ping ^a   Zhuo, Zhong Xiong ^a   Liu, Zheng ^a   Hua, Xing ^a   Zhuo, Qin Qiang ^a   Xia, Hong Mei ^a   Gao, Yun Hua ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Molecular imaging; Ultrasound contrast agent; Vascular endothelial growth factor receptor 2; Vulnerable plaques

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; VASCULOTROPIN RECEPTOR 2;

ANIMAL; ARTICLE; ATHEROSCLEROTIC PLAQUE; ECHOGRAPHY; EVALUATION; MALE; METABOLISM; METHODOLOGY; MICROBUBBLE; NEOVASCULARIZATION (PATHOLOGY); RABBIT;

ANIMALS; CONTRAST MEDIA; MALE; MICROBUBBLES; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC; RABBITS; ULTRASONOGRAPHY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 78650969700     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.20759     Document Type: Article

References (25)

1. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005; 25: 2054.
2. Moulton KS, Vakili K, Zurakowski D, et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003; 100: 4736.
3. Barger AC, Beeuwkes R, Lainey LL, et al. Hypothesis: vasa vasorum and neovascularization of human coronary arteries-a possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984; 310: 175.
4. Depre C, Havaux X, Wijns W. Neovascularization in human coronary atherosclerotic lesions. Cathet Cardiovasc Design 1996; 39: 215.
5. Brogi E, Wu T, Namiki A, et al. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994; 90: 649.
6. Gerber HP, McMurtrey A, Kowalski J, et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 1998; 273: 30336.
7. Macioch JE, Katsamakis CD, Robin J, et al. Effect of contrast enhancement on measurement of carotid artery intimal medial thickness. Vasc Med 2004; 9: 7.
8. Neems RFM, Goldin M, Dainauskas J, et al. Real-time contrast enhanced ultrasound imaging of the neovascularization within the human carotid plaque. J Am Coll Cardiol 2004; 43: 374.
9. Magnoli MCS, Melisurgo G, De Dominicis D, et al. Contrast enhanced B-flow imaging for the evaluation of periadventitial vasa vasorum in humans. Presented at: Proceeding of the 11th European Symposium on Ultrasound Contrast Imaging; Rotterdam, the Netherlands, 2006.
10. Villanueva FS, Jankowski RJ, Klibanov S, et al. Microbubbles targeted to intercellular adhesionmolecule-1 bind to activated coronary artery endothelial cells. Circulation 1998; 98: 1.
11. Kheirolomoom A, Dayton PA, Lum AF, et al. Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. J Control Release 2007; 118: 275.
12. Chen WQ, Zhang L, Liu YF, et al. Prediction of atherosclerotic plaque ruptures with high-frequency ultrasound imaging and serum inflammatory markers. Am J Physiol Heart Circ Physiol 2007; 293: H2836.
13. Chen WQ, Zhang Y, Zhang M, et al. Establishing an animal model of unstable atherosclerotic plaques. Chin Med J (Engl) 2004; 117: 1293.
14. Zhang L, Liu Y, Lu X, et al. Intraplaque injection of Ad5-CMV.p53 aggravates local inflammation and leads to plaque instability in rabbits. J Cell Mol Med 2009; 13: 2713.
15. Lin HL, Xu XS, Lu HX, et al. Pathological mechanisms and dose dependency of erythrocyte-induced vulnerability of atherosclerotic plaques. J Mol Cell Cardiol 2007; 43: 272.
16. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108: 1664.
17. Constantinides P. Cause of thrombosis in human atherosclerotic arteries. Am J Cardiol 1990; 66: 37G.
18. Gossl M, Versari D, Hildebrandta H, et al. Vulnerable plaque: detection and management. Med Clin North Am 2007; 91: 573.
19. Vicenzini E, Giannoni MF, Benedetti-Valentini F, et al. Imaging of carotid plaque angiogenesis. Cerebrovasc Dis 2009; 27: 48.
20. Giannoni MF, Vicenzini E, Citone M, et al. Contrast carotid ultrasound for the detection of unstable plaques with neoangiogenesis: a pilot study. Eur J Vasc Endovasc Surg 2009; 37: 722.
21. Weller GE, Lu E, Csikari MM, et al. Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation 2003; 108: 218.
22. Bachmann C, Klibanov AL, Olson TS, et al. Targeting mucosal address in cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease. Gastroenterology 2006; 130: 8.
23. Moreno PR, Purushothaman KR, Fuster V, et al. Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation 2002; 105: 2504.
24. Celletti FL, Waugh JM, Amabile PG, et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001; 7: 425.
25. Inoue M, Itoh H, Ueda M, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 98: 2108.